Merck KGaA's stock remains a 'hold' due to its high valuation, trading at an earnings multiple of around 20 and a 4.5% free cash flow yield. Read why MKGAF is a hold.

Investing.com – U.S. stocks were lower after the close on Monday, as losses in the Oil & Gas, Technology and Industrials sectors... Investing.com – U.S. stocks were lower after the close on ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

Investing.com – U.S. stocks were higher after the close on Monday, as gains in the Healthcare, Technology and Basic Materials... By Tamara Mathias (Reuters) - Merck & Co's (N:MRK ...

The stock of Merck MRK has declined 19.2% in the past six months, losing almost $52 billion of its market value The numerous challenges plaguing the company resulted in the dilution of the stock ...

Merck's stock trades at a low valuation as investors worry about Keytruda's looming patent cliff. The company is looking to a new, subcutaneous formulation, which could help sales remain strong.